| Record ID | ia:fromalchemytoipo00robb |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/fromalchemytoipo00robb/fromalchemytoipo00robb_marc.xml |
| Download MARC binary | https://www.archive.org/download/fromalchemytoipo00robb/fromalchemytoipo00robb_meta.mrc |
LEADER: 04895cam 2200769 a 4500
001 ocm44078478
003 OCoLC
005 20101006191820.0
008 000518s2000 maua 001 0 eng
040 $aNLM$cNLM$dBKL$dEYE$dVPL$dBAKER$dNLGGC$dBTCTA$dYDXCP$dCGC$dNZAUC$dFVC$dDRB$dWEN$dSINLB$dDEBBG
016 7 $a100958292$2DNLM
020 $a0738202533
020 $a9780738202532
035 $a(OCoLC)44078478
042 $anlmcopyc
050 00 $aTP248.2$b.R63 2000
050 4 $aHD9999.B44$bR62 2000
060 00 $a2000 G-610
060 10 $aHD 9999.B442$bR635f 2000
082 00 $a660.6$221
082 04 $a338.476606$221
084 $a58.30$2bcl
084 $aQR 529$2rvk
100 1 $aRobbins-Roth, Cynthia.
245 10 $aFrom alchemy to IPO :$bthe business of biotechnology /$cCynthia Robbins-Roth.
260 $aCambridge, Mass. :$bPerseus,$cc2000.
300 $axv, 253 p. :$bill. ;$c24 cm.
500 $aIncludes index.
505 0 $aPart 1 The Roots of Biotechnology -- Biotech in the Beginning -- Genentech: The Leader of the Pack -- The Amgen Story -- An Exception to Every Rule: Genzyme -- The Other Biotech: Monoclonal Antibodies -- Part 2 Biotechʼs Building Blocks -- Biotech Star Wars -- The Human Genome Project -- Tools for Genome Studies: BioChips and Microarrays -- Treating Disease at the Gene: Antisense Drugs -- Gene Therapy -- Following the Path of Communication: Signal Transduction -- Brand-New Knees: Tissue Engineering and Cell Replacement -- Building New Drugs: Combinatorial Chemistry -- Agricultural Biotechnology -- Part 3 The Business of Biotech: Product Development and Financing -- The Drug Development Process: From Test Tubes to Patients -- Speed Bumps and Brick Walls: Clinical Trial Design -- Biotech Bankers -- Initial Public Offerings -- Creative Financing -- Corporate Partners and the Urge to Merge -- Part 4 Biotech Stocks -- The Biotech Stock Landscape -- Picking the Right Stocks -- Appendix A Biotech Timeline -- Appendix B Biotechnology-Derived Products on the Market -- Appendix C Biotech Web Sites and Resources -- Appendix D BioVenture Consultantsʼ Biotech Stock Report.
520 $aIt is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.
650 12 $aBiotechnology.
650 22 $aBiomedical Technology.
650 22 $aIndustry.
650 17 $aBiotechnologie.$2gtt
650 0 $aBiotechnology.
650 07 $aBiotechnologie.$2swd
650 07 $aBiotechnologische Industrie.$2swd
651 7 $aUSA.$2swd
938 $aBaker & Taylor$bBKTY$c26.00$d19.50$i0738202533$n0003463828$sactive
938 $aBaker and Taylor$bBTCP$nbl 00013276
938 $aYBP Library Services$bYANK$n1655410
952 $a44078478$zNLM$bNATIONAL LIBR OF MED$hFull$iLCC$jNLM$kDDC$nSummary$pnlmcopyc$tContents$u20100530
952 $a125244853$zSCUHF$bSANTA CLARA UNIV, HEAFEY LAW LIBR$hFull$u20100711
952 $a182876583$zXOX$bPALO ALTO RES CTR$hFull$jNLM$pnlmcopyc$u20100718
952 $a189483344$zPAU$bUNIV OF PENNSYLVANIA$hFull$iLCC$u20100729
952 $a215386836$zCUY$bUNIV OF CALIFORNIA, BERKELEY$hFull$u20100719
952 $a224602233$zCLS$bHARVARD UNIV, CABOT SCI LIBR$hFull batch$iLCC$u20100708
952 $a230487868$zHBS$bHARVARD UNIV, BUSINESS SCH, BAKER LIBR$hFull batch$iLCC$u20100715
952 $a230487874$zHBS$bHARVARD UNIV, BUSINESS SCH, BAKER LIBR$hFull batch$iLCC$u20100803
952 $a230487877$zHBS$bHARVARD UNIV, BUSINESS SCH, BAKER LIBR$hFull batch$iLCC$u20100723
952 $a230487879$zHBS$bHARVARD UNIV, BUSINESS SCH, BAKER LIBR$hFull batch$iLCC$u20100729
952 $a230487881$zHBS$bHARVARD UNIV, BUSINESS SCH, BAKER LIBR$hFull batch$iLCC$u20100710
952 $a239433825$zHLS$bHARVARD UNIV, HARVARD COL LIBR$hFull batch$iLCC$u20100630
952 $a275591534$zSTF$bSTANFORD UNIV LIBR$hFull OCLC member$u20100627
952 $a484547266$zN15$bNEW YORK UNIV, GROUP BATCHLOAD$hFull$iLCC$u20100701
952 $a484547335$zN15$bNEW YORK UNIV, GROUP BATCHLOAD$hFull$iLCC$u20100720
952 $a485875191$zTEU$bTEMPLE UNIV$hFull$u20100716
029 0 $aNLM$b100958292
029 1 $aNLGGC$b216942209
029 1 $aYDXCP$b1755948
029 1 $aYDXCP$b1655410
029 1 $aNZ1$b6024369
029 1 $aAU@$b000022391999
029 1 $aAU@$b000022527271
029 1 $aDEBBG$bBV013372580
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 436 OTHER HOLDINGS